The development of digital solutions for different types of biomarkers; these solutions can be analyzed in silico, for a variety of diseases

Advances in information technology and biomedical science have enabled the development of digital solutions for biomarkers, which, owing to the myriad of pertinent applications, are being increasingly adopted in modern healthcare practices.

 

• An overview of the current market landscape of digital solutions for biomarkers, including information on current status (approved, marketed, USFDA submission, research and development, proof-of-concept, and discovery), content of solution (combination offering of  software application / gaming solution + AI support or device or personal coach, and standalone software / gaming solution ), purpose of solution (diagnosis, early screening, monitoring and predictive insights), type of biomarker (cognitive, idiosyncratic, molecular, neurophysiological, physiological, respiratory, vocal, and others ), target indication(s), therapeutic area(s), target population, and prescription requirement. In addition, it highlights the companies engaged in developing digital solutions for biomarkers, along with information on their year of establishment, company size, type of business model used (B2B and B2C) and location of headquarters.
• An in depth analysis of the contemporary market trends, presented using five schematic representations, including [A] a bubble analysis comparing the leading players engaged in the development of digital solutions for biomarkers, based on various parameters (such as product portfolio strength, type of biomarker and company size), [B] a grid representation illustrating the distribution of digital solutions for biomarkers based on their current status, content of solution and target therapeutic area, [C] an insightful tree map representation of digital solutions for biomarkers based on their therapeutic area and company size, [D] a world map representation highlighting the regional distribution of developer companies, and [E] a comparative grid representation to highlight the current and likely future market landscape based on status of development, type of biomarker and therapeutic area. 

 

To order this 270+ page report, which features 135+ figures and 140+ tables, please visit https://www.rootsanalysis.com/reports/digital-biomarkers-market.html

 

The USD 8.86 billion (by 2030) financial opportunity within the digital therapeutics market has been analyzed across the following segments:

• Type of Solution
• Standalone Software Application
• Software Application + Device + Personal Coach
• Software Application + Device + AI Support
• Software Application + Device
• Software Application + AI Support
• Software Application + Personal Coach
• Other Types of Solutions

 

• Purpose of Solution
• Medication Replacement
• Medication Augmentation

 

• Type of Therapy
• Curative
• Preventive

 

• Business Model
• Business to Consumer (Patients and Caregivers)
• Business to Business (Healthcare Providers, Payers, Employers and Pharmaceutical Companies)

 

• Therapeutic Areas
• Cardiovascular Disorders
• Chronic Pain
• Mental Health Problems
• Metabolic Disorders
• Neurological Disorders
• Respiratory Disorders
• Sleep Disorders
• Substance Use Disorders
• Others

 

• Key Geographical Regions
• North America
• Europe
• Asia-Pacific
• Rest of the world

 

The Digital Solutions for Biomarkers Market, 2021-2030, report features the following companies, which we identified to be key players in this domain:

• Akili Interactive
• AiCure
• Cogito Corp
• Janssen Pharmaceuticals
• Huma
• Mindstrong Health
• Oura
• Pear Therapeutics
• Roche
• Sonde Health
• Vocalis Health
• Winterlight Labs

 

Table of Contents

 

1. Preface

2. Executive Summary

3. Introduction
 

4. Market Landscape
 

5. Key Market Insights

 

6. Company Profiles
 

7. Product Competitiveness Analysis

 

9. Global Events Analysis

 

8. Funding and Investment Analysis

 

9. Partnerships and Collaborations
 

10. Go-To-Market Strategy
 

11. Big Pharma Initiatives
 

12. Market Forecast
 

13. Impact of COVID-19 Pandemic on Digital Solutions for Biomarkers Market
 

14. Conclusion

 

15. Appendix 1: Tabulated Data

 

16. Appendix 2: List of Companies and Organizations

 

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/digital-biomarkers-market.html

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

[email protected]